BEXSON
LIVE

Serial Number

97583883

Owner

Bexson Biomedical, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Sep 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BEXSON Trademark

Serial Number: 97583883

BEXSON is a trademark filed by Bexson Biomedical, Inc. on September 8, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Bexson Biomedical, Inc. (4 trademarks)

856 Chelham Way
Santa Barbara, CA 93108

Entity Type: 03

Trademark Details

Filing Date

September 8, 2022

Registration Date

Not Registered

Published for Opposition

August 15, 2023

Goods & Services

pharmaceutical preparations for reducing, managing and relieving pain, treating addiction disorders and treating mental health illnesses; pharmaceutical preparations consisting of ketamine, flumazenil and psychedelics for the treatment of pain, addiction disorders and mental health illnesses; pharmaceutical preparations, namely, medicinal psychoactive psychedelic therapies for the treatment of pain, addiction disorders and mental health illnesses; drug delivery agents in the form of small molecules for the controlled release of therapeutic agents; wearable drug delivery devices, namely, subcutaneous pumps, sold filled with pharmaceutical preparations, for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses

providing business information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor

providing regulatory compliance information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor

providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor

wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses

medical and scientific research in the fields of addiction disorders, mental health illnesses, pain management, reduction and relief; developing modular subcutaneous delivery platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drugy delivery devices therefor

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 11, 2025 EXRA
SOU EXTENSION 4 GRANTED
Oct 10, 2025 EX4G
SOU EXTENSION 4 FILED
Oct 10, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 9, 2025 EXRA
SOU EXTENSION 3 GRANTED
Apr 8, 2025 EX3G
SOU EXTENSION 3 FILED
Apr 8, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 8, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 4, 2024 EXRA
SOU EXTENSION 2 GRANTED
Oct 4, 2024 EX2G
SOU EXTENSION 2 FILED
Oct 4, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 4, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 16, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 16, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 16, 2024 AITU
SOU EXTENSION 1 FILED
Apr 9, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 9, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 10, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 12, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 12, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 12, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 12, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 12, 2023 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 11, 2023 GNFN
FINAL REFUSAL E-MAILED
Jul 11, 2023 GNFR
FINAL REFUSAL WRITTEN
Jul 11, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2022 NWOS
NEW APPLICATION ENTERED
Sep 12, 2022 NWAP